Point of Care Diagnostics Market by Mode (OTC, Prescription), Product (Coagulation, Glucose, Infectious Disease), Platform (Immunoassays, Microfluidics), End-User (Hospitals, Home Care) – 2020 to 2025

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 17, 2020
Clear
SKU: GMS-2026 Category:

The diagnostic point-of-care market is expected to hit USD 48.2 billion by 2025, rising at a CAGR of 9.65% during the forecast period. The growth of the market is driven by factors such as the high prevalence of infectious diseases in developing countries, increased incidence of target conditions, increased government funding and increased preference for home healthcare worldwide.

Point of Care Diagnostics Market by Mode (OTC, Prescription), Product (Coagulation, Glucose, Infectious Disease), Platform (Immunoassays, Microfluidics), End-User (Hospitals, Home Care) - 2020 to 2025 1

Point of Care Diagnostics Market by Mode (OTC, Prescription), Product (Coagulation, Glucose, Infectious Disease), Platform (Immunoassays, Microfluidics), End-User (Hospitals, Home Care) - 2020 to 2025 2

Point of Care Diagnostics Market by Mode (OTC, Prescription), Product (Coagulation, Glucose, Infectious Disease), Platform (Immunoassays, Microfluidics), End-User (Hospitals, Home Care) - 2020 to 2025 3

Point of Care Diagnostics Market by Mode (OTC, Prescription), Product (Coagulation, Glucose, Infectious Disease), Platform (Immunoassays, Microfluidics), End-User (Hospitals, Home Care) - 2020 to 2025 4

Point of Care Diagnostics Market by Mode (OTC, Prescription), Product (Coagulation, Glucose, Infectious Disease), Platform (Immunoassays, Microfluidics), End-User (Hospitals, Home Care) - 2020 to 2025 5

Point of Care Diagnostics Market by Mode (OTC, Prescription), Product (Coagulation, Glucose, Infectious Disease), Platform (Immunoassays, Microfluidics), End-User (Hospitals, Home Care) - 2020 to 2025 6

Point of Care Diagnostics Market by Mode (OTC, Prescription), Product (Coagulation, Glucose, Infectious Disease), Platform (Immunoassays, Microfluidics), End-User (Hospitals, Home Care) - 2020 to 2025 7

Point of Care Diagnostics Market by Mode (OTC, Prescription), Product (Coagulation, Glucose, Infectious Disease), Platform (Immunoassays, Microfluidics), End-User (Hospitals, Home Care) - 2020 to 2025 8

1 Global Point of Care Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Point of Care Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Point of Care Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Point of Care Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Point of Care Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Point of Care Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Point of Care Diagnostics Market – By Product (Market Size – & million/billion)
8.1 Glucose Monitoring Products
8.2 Cardiometabolic Monitoring Products
8.3 Coagulation Monitoring Products
8.4 Infectious Disease Testing Products
8.5 Tumor/Cancer Marker Testing Products
8.6 Cholesterol Testing Products
8.7 Hematology Testing Products
8.8 Fecal Occult Testing Products
8.9 Others

9 Global Point of Care Diagnostics Market – By Platform
9.1 Lateral Flow Assays
9.2 Dipsticks
9.3 Microfluidics
9.4 Molecular Diagnostics
9.5 Immunoassays

10 Global Point of Care Diagnostics Market – By End-User
10.1 Clinical Laboratories and Outpatient Healthcare & Ambulatory Care Settings
10.2 Hospitals/Critical Care Centers
10.3 Home Care Settings
10.4 Other

11 Global Point of Care Diagnostics Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Point of Care Diagnostics Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Point of Care Diagnostics Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Abbott Laboratories
13.3 Becton, Dickinson, and Company (BD)
13.4 Chembio Diagnostics
13.5 EKF Diagnostics
13.6 Quidel
13.7 Trinity Biotech
13.8 Danaher Corporation
13.9 Siemens Healthineers Group
13.10 Johnson & Johnson
13.11 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
13.12 Company 11 & more

14 Global Point of Care Diagnostics Market – Appendix
14.1 Sources
14.2 Abbreviations